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A neuromuscular exercise programme
versus standard care for patients with
traumatic anterior shoulder instability:
study protocol for a randomised controlled
trial (the SINEX study)
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Abstract
Background: Anterior shoulder dislocation is a common injury and may have considerable impact on shoulder-
related quality of life (QoL). If not warranted for initial stabilising surgery, patients are mostly left with little to no
post-traumatic rehabilitation. This may be due to lack of evidence-based exercise programmes. In similar, high-
impact injuries (e.g. anterior cruciate ligament tears in the knee) neuromuscular exercise has shown large success in
improving physical function and QoL. Thus, the objective of this trial is to compare a nonoperative neuromuscular
exercise shoulder programme with standard care in patients with traumatic anterior shoulder dislocations (TASD).
Methods/design: Randomised, assessor-blinded, controlled, multicentre trial. Eighty patients with a TASD will be
recruited from three orthopaedic departments in Denmark. Patients with primary or recurrent anterior shoulder
dislocations due to at least one traumatic event will be randomised to 12 weeks of either a standardised, individualised
or physiotherapist-supervised neuromuscular shoulder exercise programme or standard care (self-managed shoulder
exercise programme). Patients will be stratified according to injury status (primary or recurrent). Primary outcome will
be change from baseline to 12 weeks in the patient-reported QoL outcome questionnaire, the Western Ontario
Shoulder Instability Index (WOSI).
Discussion: This trial will be the first study to compare the efficacy and safety of two different nonoperative exercise
treatment strategies for patients with TASD. Moreover, this is also the first study to investigate nonoperative treatment
effects in patients with recurrent shoulder dislocations. Lastly, this study will add knowledge to the shared decision-
making process of treatment strategies for clinical practice.
Trial registration: ClinicalTrials.gov, identifier: NCT02371928. Registered on 9 February 2015 at the National Institutes of
Health Clinical Trials Protocol Registration System.
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Background
Traumatic anterior shoulder dislocation (TASD) is a
common injury [1], especially within the second and
third decades of life in young, active individuals [2], with
a yearly incidence rate in the general population
reported to be from 11.2 to 26.2 per 100,000 persons
[3–7]. Following a first-time TASD, the risk for recurrent
dislocations is high due to pathophysiological changes in
the shoulder joint [8] with mean risk rates estimated to
vary between 39% and 67% [4, 9, 10]. Recurrent disloca-
tions may be serious with shoulder function being fur-
ther compromised by every dislocation. Hence, patients
are frequently limited in sports-related and social activ-
ities affecting quality of life (QoL) [11–14].
Treatment-wise, systematic reviews advocate for initial
stabilising surgery in young, highly athletic, active, male
patients with a primary TASD [1, 15] in spite of the
expressed concern that early surgery exposes patients to
unnecessary surgery-related complications and adds to
societal treatment costs [16]. For other TASD patients
(e.g. those aged 25–40 years, nonprofessional athletes,
primary or recurrent dislocations) the evidence for opti-
mal treatment (operative as well as nonoperative) is lim-
ited [1, 17]. Traditionally, post-traumatic standard care
consists of closed reduction, followed by immobilisation
in a shoulder sling and, if provided, some kind of physio-
therapy [18]. Currently, there is no evidence-based exer-
cise programme to prescribe for patients with TASDs [8]
and the quantity and quality of studies investigating
nonoperative treatment for this patient group is low
[19]. Three randomised controlled trials (RCTs) investi-
gating the effect of nonoperative (shoulder rehabilita-
tion) versus operative treatment (arthroscopic or open
Bankart procedures in addition to shoulder rehabilita-
tion) in patients with primary TASD show that early op-
erative reconstruction of the anterior capsulolabral
complex is superior to nonoperative treatment in redu-
cing redislocation rates [20–22]. However, the shoulder
rehabilitation programmes used in these RCTs are
poorly described making it difficult to reproduce, and
they consist mostly of postoperative exercise principles.
Thus, the nonoperatively treated patients may have been
undertreated with specialised, intensive, nonoperative
exercise regimes lacking [23]. Also, varying methodo-
logical issues exist that are expected to bias the findings
of the RCTs [19, 23].
In other body regions, neuromuscular exercise has
shown great potential in reducing joint pain, besides im-
proving functional capacities and QoL [24–27]; e.g.
neuromuscular exercise has shown to be as equally
effective as early surgical reconstruction in patients with
traumatic anterior cruciate ligament injuries in the knee,
which is comparable with TASD on injury mechanism
(traumatic origin, high impact), age (late teens to mid-
30s), post-traumatic symptoms (pain, instability, loss of
mechanical stability), besides reduction in physical and
social function [24]. Hence, neuromuscular exercise also
seems evident for patients with TASD due to loss of
mechanical stability [28], and potentially impaired pro-
prioceptive functions [29–31]. To our knowledge, such
neuromuscular exercise programmes for increasing sen-
sorimotor control and compensatory functional stability
[25] have not yet been developed and tested scientifically
on the shoulder [32].
In conclusion, the evidence for optimal treatment of
patients with TASD (primary and recurrent) is lacking,
and previous exercise programmes are poorly described
and do not include the newest physiological knowledge
for improving joint instability deficits. Sufficiently pow-
ered, good-quality and well-reported RCTs are needed to
investigate nonoperative rehabilitation strategies in pa-
tients with TASD [33].
Study objectives
The aim of this randomised controlled clinical trial is to
evaluate the efficacy and safety of a 12-week, structured
‘Shoulder Instability Neuromuscular Exercise’ (SINEX)
programme versus 12 weeks of a self-managed, training-
based, shoulder exercise programme (‘standard care’),
measured on the Western Ontario Shoulder Instability
Index (WOSI) questionnaire [34] in patients with TASD
(primary and recurrent). It is hypothesised that patients
receiving 12 weeks of SINEX training will show superior
improvement in short- and long-term shoulder-related
QoL and function.
Methods/design
Study design
This trial is a multicentre research project in cooper-
ation with three orthopaedic shoulder units in The Re-
gion of Southern and Northern Denmark. The study is a
randomised (1:1), assessor-blinded, controlled trial with
a parallel-group design investigating the efficacy and
safety of a ‘SINEX training programme’ versus standard
care for patients with TASD (primary and recurrent)
with a primary endpoint after 12 weeks (3 months). The
primary endpoint of 12 weeks was chosen since the pri-
mary effect measure is a patient-reported shoulder-
related QoL outcome and not, as in previous trials,
whether the shoulder dislocates or not. Thus, if there is
no significant short-term effects of the SINEX
programme, it is highly unlikely that there will be any
long-term effects. Furthermore, long-term follow-up will
be performed for all patients between 1 and 2 years from
baseline. The protocol conforms to the recommenda-
tions from the EQUATOR network [35], using the
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) Checklist and Consolidated
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Standards of Reporting Trials (CONSORT) guidelines
for RCTs [36, 37] Additional file 1.
Settings and locations
Patients are recruited from shoulder outpatient clinics of
orthopaedic departments in the Region of Northern
Denmark (Aalborg University Hospital, Farsoe) and
Southern Denmark (South-West Jutland Hospital,
Esbjerg and Odense University Hospital, Odense).
Participants
Participants included are classified as dynamic shoulder
instability types (class B2) according to Gerber et al. [38],
referring to patients with unidirectional shoulder instabil-
ity initiated by trauma. Both men and women with pri-
mary or recurrent anterior shoulder dislocations are
included, provided that they fulfil the following criteria:
Inclusion criteria
1. Age between 18 and 39 years
2. Minimum one radiographically verified anterior
shoulder dislocation (total dissociation of the
humeral head relative to the glenoid)
3. Self-reported shoulder trouble (physical and/or
emotional), meaning diminished ability to participate
or perform shoulder movements needed in sports/
leisure activity and/or work tasks within the latest
week
Exclusion criteria (any of the following)
1. Humeral fracture and/or bony Bankart lesion (visible
on conventional radiographs at the time of
presentation) warranted for surgery as decided by
the orthopaedic surgeon
2. Prior surgery to the affected shoulder joint
3. More than five anterior shoulder dislocations
(verified by patient record or subjective evaluation)
4. Suspected competing diagnosis (e.g. rheumatoid
arthritis, cancer, neurological disorders, fibromyalgia,
psychiatric diseases)
5. Sensory and motor deficits in the neck and/or
shoulder
6. Pregnancy
7. Inadequacy in written and spoken Danish
8. Not willing or able to attend 12 weeks of supervised
SINEX therapy
Procedure
Patients consulting emergency departments with a
TASD will be treated according to standard procedures
consisting of shoulder reduction followed by sling
immobilisation in internal rotation and use of analgesics,
if needed. After completion of the subacute phase (3–6
weeks) patients will attend one of the participating
shoulder units for a routine check of the actual shoulder
function. Potential candidates are then identified and
screened for initial eligibility by an orthopaedic surgeon
according to inclusion criteria 1–2 and exclusion criteria
1–5. Patients fulfilling the eligibility criteria are referred
to the principal investigator (first author), who performs
the final eligibility assessment according to inclusion
criterion 3 and exclusion criteria 5–8. All patients are
provided with written and verbal information about the
study objectives, and a signed consent is obtained for
those eligible and willing to participate. Patients not
included or declining to participate will be asked to fill
out the WOSI questionnaire, and report age and gender
so as to improve the selection bias analysis.
Randomisation and concealment of allocation
Patients are randomly assigned to either of the two
groups. An independent biostatistician, with no involve-
ment in the clinical care of the patients, prepares a
computer-generated list of random numbers (1:1), which
is subsequently packed at each trial site into sequentially
numbered, opaque, concealed envelopes, stating which
group each individual is allocated to. Patients are strati-
fied based on injury status: (1) primary (first time) or (2)
recurrent (second to fifth) dislocations.
At each recruitment site, envelopes are stored in a
closed room and managed by a single research assistant.
After randomisation the same research assistant for-
wards group assignments to the treating physiotherapist
who contacts the patient for an appointment of the first
exercise instruction. Patients are reassessed after
3 months (12 weeks of exercise) and again after 12
(52 weeks) and 24 months (104 weeks). A flowchart of
participants and randomisation is presented in Fig. 1.
Blinding
The primary investigator and one research assistant, per-
forming outcome measurements, are blinded according
to treatment allocation and not involved in the treat-
ment of patients. Though, blinding of treatment alloca-
tion for patient and physiotherapist is not possible.
Patients involved are thoroughly informed (written and
orally) that the optimal choice of treatment is truly un-
known, thereby keeping the study hypothesis secret [36].
Further, to retain the blinding of the outcome assessors,
patients are encouraged not to reveal their treatment
assignment. Finally, all of the statistical analyses will be
performed blinded according to group allocation and
results will be interpreted in an author consensus state-
ment prior to disclosing/revealing group allocation.
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Interventions
Both groups receive 12 weeks of active exercise treat-
ment, information on correct ergonomic postures and
instructions in active range of motion exercises and/or
stretching of shoulder muscles if needed. Patients are
asked not to seek other treatment for their current
shoulder problem during the intervention period. After
the end of intervention patients will be advised to con-
tinue their exercises and allowed to seek other treatment
options. Patients experiencing additional dislocations or
worsening of shoulder symptoms during the interven-
tion period will be referred to an orthopaedic surgeon
for a clinical evaluation of whether they can continue in
the study. Withdrawn patients, due to either worsening
of symptoms, surgery and/or retraction of participation
consent, will be asked to complete all follow-up mea-
surements to ensure a full dataset. Finally, patients are
asked to fill out an exercise diary in relation to their
home-based exercises.
Control group
Participants allocated to standard care will begin their
12 weeks of self-managed training-based shoulder exer-
cise programme with one introductory supervised
physiotherapy session. Standard care consists of active
exercises for the rotator cuff and scapular muscles as fol-
lows: strengthening exercises for the rotator cuff muscles
(shoulder internal and external rotation with the sub-
ject’s elbow flexed to 90° and the elbow positioned at the
subject’s side in addition to shoulder abduction per-
formed inthe scapular plane. Mobility/co-activation of
the scapular and core stability muscles is performed
through the weight-bearing, four-point kneeling exercise,
with simultaneous lift-off of one arm and the opposite
Fig. 1 Flowchart of the Shoulder Instability Neuromuscular Exercise (SINEX) study
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leg. Patients are asked to perform the exercises three
times weekly with 10 × 2 repetitions for each exercise.
Participants are initially provided with a leaflet contain-
ing photos and descriptions of each exercise, besides
general information about their current shoulder injury,
potential future implications, and how to avoid pain and
instability provoking shoulder movements. Finally, par-
ticipants receive one phone call from a physiotherapist
after 6 weeks of training to ensure progression and com-
pliance with the exercises, in addition to having any
patient-initiated communication that the patient may
want to have regarding further shoulder-related ques-
tions. Patients allocated to standard care will be regarded
as having completed the intervention with a minimum
of two thirds (66%) of the planned home training.
Intervention group
Participants allocated to the SINEX programme receive
12 weeks of individually physiotherapist-supervised exer-
cise specifically, targeting the glenohumeral and scapular
muscles. Moreover, functional kinetic chain exercises are
incorporated for progressing to more difficult levels,
mimicking daily activities and improving the transfer-
ability of everyday activities.
The SINEX programme is individually tailored within
a standardised framework consisting of seven exercises
(1–7): scapular setting and control (1), glenohumeral
setting and control during internal (2) and external (3)
rotation, co-contraction of glenohumeral muscles (4),
dynamic glenohumeral stability (5), besides training of
glenohumeral proprioception (6, 7).
Each exercise includes seven levels (A to G) of diffi-
culty, ranging from a basic to an elite level. Exercises at
the basic level (A to E) are performed with low load,
large body support and focus on local shoulder muscle
activity (quality before quantity). Exercises at the elite
level (F to G) are performed with high load, less body
support and increasing movement speed, according to
the individual capability of each patient. The load and
repetitions of each exercise are performed as follows;
exercises 1–4 are performed according to the principle
of strength training, meaning that basic and elite levels
refer to low- and high-load training equal to 2 × 20–25
and 2 × 8–12 of 1 repetition maximum, respectively. Ex-
ercise 5 (dynamic shoulder stability) is performed with
the use of time intervals equal to 3 × 10 and 3 × 20 sec-
onds at basic and elite levels, respectively. For exercises
6 and 7 (proprioceptive training) the basic and elite
levels are performed with 2 × 5 and 2 × 10 repetitions,
respectively. Participants are instructed to perform each
exercise at home as follows; exercises at basic levels (A
to E) 7 days a week and exercises at elite levels (F to G)
three times a week.
Participants are provided with online access to instruc-
tions and video recordings of each exercise and the accom-
panying levels of progression through the physiotherapy
site www.digifys.com.
Participants are encouraged to progress exercises
themselves, where relevant, with physiotherapists then
evaluating the performance quality of each exercise at
the supervised sessions. Hence, supervised sessions are
provided throughout the 12 weeks, lasting approximately
45 min each. Supervised sessions are given twice a week
for the first 2 weeks and then once a week for the
remaining 10 weeks. Physiotherapists decide the amount
of supervision, based upon movement control and cap-
abilities of the individual patient. Participants allocated
to SINEX are considered to have satisfactory completion
of the supervised sessions with attendance of at least
seven supervised sessions (out of 14 possible sessions)
equal to 50% attendance. Furthermore, to be considered
compliant with the intervention participants must have
completed at least two thirds (66%) of the planned
home-based exercises. For quality assurance, physiother-
apists are instructed, and continuously encouraged, to
attend at least seven supervised sessions within the 12-
week intervention period. A full description of the
exercise programme, including structure, content, pro-
gression guidelines and overall concept is provided in
Additional file 2.
Physiotherapists
To be involved as a physiotherapist, attendance at two
training sessions on how to administer the individualised
supervision of patients according to the two intervention
protocols is required. Furthermore, all physiotherapists
are initially provided with a ‘pilot’ patient to practice the
individualised supervised sessions and must have com-
pleted at least 2 weeks of supervised sessions before
starting up study participants. Physiotherapists are
allowed to contact the primary investigator regarding
any exercise-based challenges that they may have,
though, without revealing treatment allocation of the in-
dividual participants.
Data collection and follow-up
Two outcome assessors (primary investigator and one
research assistant) perform all baseline and follow-up
assessments. Before and during data collection outcome
assessors train together the test procedures of objective
outcomes to unify performance and interpretation. Also,
thoroughly described test protocols for the objective out-
come measurements are prepared.
Baseline data
Table 1 describes the type of data and variables that are
collected at various stages of the project. Furthermore,
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the following demographic and descriptive data are col-
lected: gender, age, height (cm), weight (kg), injury
mechanism (fall on the arm, pull in the arm, external
force to the shoulder, other reasons), total number of
dislocations and closed reductions at emergency units,
dominant arm (left/right), injured shoulder (left/right),
previous treatment due to shoulder symptoms? (no/yes;
which treatment?), physical activity? (no/yes; h/week),
educational level and employment status; medicine con-
sumption? (no/yes; which?). Furthermore, to evaluate
‘equipoise’ [39], patients are asked to register their belief
in the effect of the assigned treatment, shortly after ran-
domisation, in relation to pain, function and QoL.
Primary outcome measure
The primary outcome measure is change from baseline
to 12 weeks in the total score of the patient-reported
outcome measurement the WOSI. The WOSI covers 21
items, ranging from 0 to 2100 (0 = no trouble) [34]
(Table 1). The WOSI has been translated and adapted
for use in Denmark, according to international guide-
lines, before inclusion of patients [40]. The WOSI is a
relevant outcome measure due to its capability of cap-
turing changes in disease-specific aspects of QoL in
shoulder instability (activity-related shoulder symptoms,
such as the ‘feeling of slipping’ and ‘being unable to trust
the shoulder’) [41, 42]. As such, the WOSI is generally
recommended as a patient-reported outcome when
evaluating treatment effects of shoulder instability [43].
Key secondary outcomes
A number of secondary patient-reported outcome mea-
sures are obtained: the four individual domains of the
WOSI covering: 10 items in ‘Physical symptoms’ (0–
1000), 4 items in ‘Sport/recreation/work’ (0–400), ‘Life-
style’ (0–400) and ‘Emotions’ (0–300), with the level of
‘no trouble’ equal to 0 accounting for all domains [34].
Also, fear of movement and reinjury is evaluated with
the use of Tampa Scale of Kinesiophobia (TSK; 17–68,
68 = highest fear of movement and reinjury) [44, 45], in
addition to pain intensity at rest, within the latest 24 h
and 7 days, respectively, using a Numeric Pain Rating
Scale (NPRS; 0–10 score, 10 = worst imaginable pain)
[46], besides patient-rated important activity with the
Pain Specific Function Scale (PSFS, 0–10 score, 10 = no
problems in performing the activity) [47]. For cost-
effective analysis the total score of the EQ-5D-5 L (−0.59
to 1 score, −0.59 = lowest health-related quality of life) is
used, whereas QoL is measured with the EQ-5D Visual
Table 1 Outcome measures to be collected
Outcome measure(s) Data collection instrument Time line for data collection
Primary
WOSI (total score) Mean score of 21 items (0–2100; 0 = no trouble) 0, 4, 8, 12, 52 and 104 weeks
Secondary (key secondary outcomes)
Physical symptoms, Sport/recreation/
work, lifestyle and emotions
Individual domains in the WOSI 0, 12, 52 and 104 weeks
Fear of movement and reinjury Tampa Scale of Kinesiophobia 0, 12, 52 and 104 weeks
General health EQ-5D-5 L 0, 12, 52 and 104 weeks
Pain intensities Numeric Pain Rating Scales 0, 12, 52 and 104 weeks
Self-reported shoulder function Patient Specific Functioning Scale 0 and 12 weeks
Self-reported and objective shoulder function Constant-Murley Shoulder Score 0 and 12 weeks
Clinical shoulder instability Clinical tests: apprehension, relocation and surprise 0 and 12 weeks
Shoulder proprioception (open chain) Shoulder joint repositioning with use of laser
pointer method
0 and 12 weeks
Shoulder proprioception (closed chain) Nintendo Wii balance board 0 and 12 weeks
Maximum isometric shoulder muscle strength
in 90° of abduction
Isoforce dynamometer 0 and 12 weeks
Demographic data and other measurements
Total number of dislocations/subluxations Questionnaire 0 and 12 weeks
Medication use Questionnaire 12 weeks
Treatment satisfaction Questionnaire 12 weeks
Patient-reported impression of treatment success 7-point Likert scale (GPE) (ranging from
1 = very much worse to 7 = very much improved)
Throughout
Adverse events Physiotherapist records and questionnaire Throughout
WOSI Western Ontario Shoulder Instability Index; EQ-5D-5 L EuroQol 5 dimensions; GPE Global Perceived Effect
Eshoj et al. Trials  (2017) 18:90 Page 6 of 10
Analogue Scale (EQ-VAS; 0 to 100, 0 = lowest health-
related quality of life) [48].
Secondary objective outcome measures obtained
(Table 1) are the Constant-Murley Shoulder Score
(CMS; 0–100 score, 100 = best possible shoulder func-
tion [49], as used for self-reported and objective shoul-
der function. For comparison to normative data,
strength and range of motion measurements were also
obtained for the noninjured shoulder according to the
CMS protocol [49]. Additionally, participants are
screened for generalised joint hypermobility (GJH) with
the use of Beighton’s criteria tests and criteria (0–9
score, <4 = no GJH) [50]. Beighton’s criteria have shown
to be reliable for measuring GJH [51]. Specific evalu-
ation of anterior shoulder instability is performed by the
clinical tests apprehension, relocation and surprise (posi-
tive? yes/no) [52–54]. Finally, proprioceptive shoulder
function is tested with the upper extremity in an open
kinetic chain. Briefly, the test is performed as follows:
patients are blindfolded and asked to actively reproduce
different shoulder angles within low ranges of shoulder
flexion and abduction (low equal to 60° ± 10°) using a
laser beam pointing at a target scale. This method has
previously shown satisfactory reliability [55] (Table 1).
Demographic data and other measurements
A number of other outcomes are measured at the 12-
week, 1 and 2-year follow-ups: patient-reported numbers
of visits to the general practitioner or secondary health
care system during and after the end of intervention,
number of shoulder dislocations/subluxations, number
of days sick listed from work and sport attributed to the
actual shoulder injury, besides the number of referrals to
or completed shoulder surgical procedures. Further, pa-
tients are asked to answer the question: ‘If you had the
choice, would you then consider to have stabilising
shoulder surgery performed?’ Finally, a self-rated im-
pression of recovery is measured using the Global Per-
ceived Effect Scale (GPE, seven-point Likert scale
ranging from 1 to 7, 1 = very much worse and 7 = very
much improved). The GPE is evaluated with the follow-
ing question: ‘Compared to when this treatment first
started, how would you describe your shoulder problems
this latest week?’. The answer ‘no change’ (correspond-
ing to 3 on the seven-point Likert scale) is considered a
neutral response (Table 1).
Registration of adverse events or harms is obtained as
follows; patients allocated to standard care will receive a
phone call from a physiotherapist after 6 weeks of exer-
cise; patients allocated to SINEX are monitored through-
out the 12 weeks of exercise by the supervising
physiotherapists continuously registering adverse events
or harms. In addition, all patients are asked to fill out a
short standardised questionnaire to record any adverse
effects or harms at the 12-week follow-up.
Sample size and power considerations
This study was designed as an exploratory (superiority)
trial with two groups (SINEX and standard care) using
the WOSI questionnaire, as recommended in clinical tri-
als of shoulder instability patients [19, 43, 56]. The
power and sample size calculation is based on the differ-
ences in the WOSI change score between the two
groups from baseline to the 12-week follow-up.
It is expected that the group allocated to SINEX will
improve 250 points more than the group allocated to
standard care based on the primary outcome the WOSI
at endpoint after 12 weeks. With a mean baseline WOSI
score expected to be 1100 points (range 0–2100, with
2100 as worst possible score) and a common standard
deviation assumed to be 320 [57], a sample size of 36
participants per group is required to detect a statistical
difference (significance level of 0.05, two-sided, with 90%
power). To account for possible barriers, noncompliant
patients and participants lost-to-follow-up, it was de-
cided to enrol a total sample size of 80 participants
(40:40). For practical logistical reasons, new patients will
no longer be included in the study after March 2017.
Statistical evaluation
Primary analysis will be performed at the primary end-
point (12-week intervention period).
All descriptive statistics and tests will be reported in
accordance with the recommendations of the ‘Enhancing
the QUAlity and Transparency Of health Research’
(EQUATOR) network [35]; i.e. various forms of the
CONSORT guidelines [58].
All primary analyses will follow the intention-to-treat
principle; i.e. all participants in the trial will be included
in the analysis according to the group to which they are
randomised, regardless of dropout/any departures from
allocated treatment. Missing data will be replaced using
a nonresponder imputation, in which the baseline value
is carried forward [59]. The rationale behind this type of
analysis builds on the assumption that those who
dropped out returned to their baseline WOSI score [60].
For sensitivity and exploratory purposes also a per-
protocol analysis, including those with good compliance
(as previously described) with the protocol (including
outcome assessments available after 12 weeks) will be
performed.
An analysis of covariance (ANCOVA) model will be
used to analyse mean changes in continuous endpoints.
The model will include treatment, study centre, and status
with respect to type of dislocation as fixed effects, with
the baseline value of the relevant variable as a covariate.
Categorical outcomes for dichotomous endpoints will be
Eshoj et al. Trials  (2017) 18:90 Page 7 of 10
analysed with the use of logistic regression with the same
fixed effects and covariates as the respective ANCOVA.
For the longitudinal part of the trial a linear mixed
ANCOVA model with repeated measures of the WOSI
(4, 8 and 12 weeks) will be performed to test the differ-
ence over time between the intervention and the control
group; interaction: Group × Time, with the same fixed
effects and covariates as the respective ANCOVA. For
these analyses the ‘data as observed’ will be applied (i.e.
no imputation for missing data needed). An alpha level
of 0.05 will be considered as being statistically significant
(p < 0.05, two-sided). The data analysts will be blinded to
the allocated interventions for primary analyses. In gen-
eral, results will be expressed as the difference between
group means with 95% confidence intervals and the as-
sociated p values.
Data analyses will be carried out according to a pre-
established analysis plan, publicly available before the
final patient is included, and analysed with the use of
SAS software (SAS Institute Inc., Cary, NC, USA).
Ethical considerations
Patients are informed about the randomised design with
allocation to either of the two treatment arms and also
about the content of the two treatment arms. Patients
are kept blinded for any of the study hypotheses, which
can be justified since patients are treated with either an
anticipated equivalent, or superior, treatment to what
they would have received if they did not participate in
the study. Furthermore, both patient groups are ex-
pected to benefit from participation in the study through
their respective interventions. The risk of sustaining an-
other shoulder dislocation from participating in this
study is not expected to be any higher than from regular
daily activities. Furthermore, it is not anticipated that
participation will cause any serious adverse events or
harms. The trial will meet the criteria and principles of
the Declaration of Helsinki (80) and has been approved
by the local Ethics Committee for the Region of South-
ern Denmark (project ID: S-20140093). The trial is regis-
tered at ClinicalTrials.gov (ID; NCT02371928). Approval
from The Danish Data Protection Agency is given (Jour-
nal number: 2015-57-0008)
Discussion
Traumatic anterior shoulder dislocation is common and
may decrease shoulder-related QoL. The aim of this ran-
domised controlled clinical trial is to evaluate the effi-
cacy and safety of a 12-week, structured, neuromuscular
shoulder exercise programme versus 12 weeks of self-
managed shoulder rehabilitation in patients with TASDs
measured on the WOSI questionnaire.
The current study will shed light on the effect of non-
operative treatment for patients with primary and
recurrent anterior shoulder dislocations and provide
foundation for nonoperative treatment guidelines. Add-
itionally, this trial will support evidence-based shared
decision-making processes (between physicians and
patients) in clinical practice, when patients seek ortho-
paedic and/or physiotherapy treatment for a primary or
recurrent anteriorly dislocated shoulder.
Previously, only one level-II study has succeeded in
managing TASD patients (average age 19 years) nono-
peratively by including 12 weeks of specific shoulder re-
habilitation exercise. At an average time to follow-up of
3 years 15 out of 20 patients (75%) had not redislocated
their shoulder and had returned to sport within an
average time of 3 months [61]. Thus, supervised and
adequate progressive shoulder rehabilitation, therefore,
seems evident following a TASD, but has not yet been
documented in a high-level study such as in the current
trial. Finally, no matter the treatment (operative as well
as nonoperative), fear of movement and reinjury, mood,
social support and self-motivation has shown to greatly
influence the decision on return to sport [14]. Aspects
like these are only covered by patient-reported out-
comes, supporting the use of a patient-reported out-
come as primary treatment effect measure in the
current trial.
One limitation of the present trial may be that since
little is known about the nonoperative treatment poten-
tial for patients with recurrent shoulder dislocation, the
pragmatic choice of including patients with up to a
maximum number of five dislocations may be too
broad; although, orthopaedic surgeons will screen each
patient before enrolment to make sure that no patients
with injuries warranted for shoulder surgery are
included. Furthermore, to secure an even distribution
of primary and recurrent dislocation patients in each
treatment group stratification techniques are used.
Finally, as in similar exercise trials, it is not possible to
blind either patients or physiotherapists to the treat-
ment allocation. Thus, only the testers can be blinded.
The study strengths are the rigorous inclusion cri-
teria compared with previous trials of TASDs, aiming
at a homogenous patient group with self-reported
shoulder trouble. Due to the fact that not all patients
experience post-traumatic shoulder trouble nor recur-
rent shoulder instability, unnecessary invasive proce-
dures will not initially take place in the current study,
as compared to previous RCTs performing immediate
stabilising surgery [20–22]. Finally, the use of a stan-
dardised, individualised and physiotherapist-supervised
neuromuscular shoulder exercise programme devel-
oped for accommodating all types of TASD patients
(e.g. those with severe instability and pain and those
in need of more sports-specific exercises), is an
additional strength.
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Timeline, trial status and publication plan
Recruitment of patients began March 2015 and is ex-
pected to run consecutively until March 2017. At the
time of submission of this study protocol (October
2016), the trial is ongoing and still recruiting patients.
For the time being, 50 patients have been included in
the project. Data will be analysed, interpreted and pub-
lished regardless of whether results are positive, negative
or inconclusive.
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program. (PDF 4494 kb)
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